2nd International Phlebology Symposium

November 11, 2017 | Hamburg | Germany

Phlebology Update

Developments and Outlook

About 150 members of the medical profession, therapists and care staff as well as care specialists from the medical retail trade followed Juzo’s invitation to Hamburg to find out more about medical development trends and prospects in phlebology.

Ms Prof. Dr. med. Stefanie Reich-Schupke, holder of the only German professorship of Phlebology at Ruhr University in Bochum, created a highly topical programme for this gathering. Her choice of speakers really represented the “Who’s Who” of German phlebology.  For personal reasons, she had to hand over to Ms Prof. Dr. med. Anke Strölin, Leading Consultant at Tübingen University Dermatology Clinic, who ran the event confidently. The presentations were simultaneously interpreted into English for international visitors.

In her welcoming speech, Ms Prof. Strölin emphasised how topical the presentations were and she was pleased about the interest shown by participants from the medical retail trade and the paramedic profession.

The training day was split into three lecture blocks: thromboembolism, compression and ulcus cruris venosum as well as a varicosis update.


Presentations about thromboembolism

In the opening presentation “Guideline on preventing venous thromboembolism – What’s new?”, Ms Prof. Dr. med. Sylvia Hass, Munich, reported on the status of the S3 Guideline which was updated in 2015. The guideline contains, among other things, particular recommendations for thromboembolism prevention in surgical and ambulatory medicine. According to the guideline, the risk assessment is critical, with the thrombosis risk requiring individual evaluation on a patient by patient basis. In special cases, calf-length compression stockings are recommended for thrombosis prevention on long journeys.

“Guideline on preventing venous thromboembolism – What’s new?” was the focus of the presentation by Prof. Dr. med. Anke Strölin, Tübingen. Each year, around 160,000 patients are diagnosed with deep vein thrombosis in Germany. The estimated number, however, is much higher because only 50 to 60% of all cases present typical symptoms. The initial treatment is still anticoagulation and compression. The option of using direct oral anticoagulants (DOACs), among others, is new in the S2k Guideline.  A recommendation in the guideline is early introduction of compression therapy to reduce the frequency and severity of postthrombotic syndrome (PTS).

The first topic was completed by Prof. Dr. med. E. Sebastian Debus, Hamburg, speaking on “Treatment of Postthrombotic Syndrome - State of the Art”. If conservative treatment of deep vein thrombosis (DVT) took place on its own, about 90% of patients would suffer from PTS. In order to avoid marked findings, reflux obstruction has to be restored. For this, various condition-orientated methods are available nowadays. These intervention methods proved to be safe and successful. However, accompanying compression treatment, in most cases for the rest of the life, is still unavoidable.


Presentations about compression

Justine Whitaker, Clitheroe / England gave her talk on “Can Velcro Wrap Systems Really Replace Compression Bandaging”. The simple answer is ‘no’ because only some patients can be treated this way. When assessing patients as individuals and taking account of their differentiated diagnoses, however, the answer can be ‘yes’. Additional research must consider the effect of wrap systems on different connective tissue structures as well as causes of the illness.

In his presentation “Beyond varicosis – areas of application for modern compression therapy”, Prof. Dr. med. Markus Stücker, Bochum, examined additional areas of application for compression treatment, going beyond phlebology, lymphology and scar therapy. Scientific studies show that previous compression stocking contra-indications may turn into indications. Under certain conditions, this may be the case for PAOD for example, or for specific inflammatory skin diseases.


Presentations about ulcus cruris venosum as well as a varicosis update

Ms PD Dr. med. Felizitas Pannier, Bonn, had prepared two presentations. First, she spoke about her positive experience with “Endovenous laser treatment”, which she has been performing successfully for 18 years. Over time, this method has become increasingly gentle. The latest development of the radial emitting laser has also contributed to this. She also pointed out limits of this treatment that preserves the vessels, such as extremely tortuous saphenous veins. In her presentation “Sclerotherapy - and what is possible”, Dr. Pannier then talked about chemical varicose vein treatment. According to her conclusion, sclerotherapy has now become the only treatment that can be used on all varicose veins.

“Update - surgical treatment of varicosis” was the topic of the presentation by Prof. Dr. med. Achim Mumme, Bochum. In his experience, modern varicose vein surgery results in a high degree of patient satisfaction with very low recurrence rates. Surgical planning and technique are critical for this, such as invaginated stripping of the vein. During this particularly gentle technique, the vein, which is to be stripped, is turned inside out. He gave endoluminal valvuloplasty, in a sense a compression stocking around the vein, as another example. His concluding message: “Modern varicose vein surgery: Gentle - differentiated - effective - long-lasting”

As part of the symposium, Sarah Conen, Juzo Phlebology Product Management, presented a donation cheque of 5,000 Euro to Prof. Stücker, President of the German Association for Phlebology. With this, Juzo would like to support the work of the “Young Phlebology” task force.

Scientific leaders and organisers were pleased with the good response to this international symposium.  The feedback from guests and speakers was also positive throughout.

The 3rd International Phlebology Symposium will take place on 24 November 2018 in Munich.




PD. Dr. med. Felizitas Pannier, Bonn

Fachärztin für Dermatologie, Praxis für Dermatologie und Phlebologie, Klinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Köln

Prof. Dr. med. Sebastian Debus, Hamburg

Director of the Clinic of Vascular Medicine
University Hospital Hamburg-Eppendor

Prof. Dr. med. Sylvia Haas, Munich

General Practitioner

Prof. Dr. med. Birgit Kahle, Lübeck

Senior Physician
Clinic of Dermatology, Allergology
and Venereology

Prof. Dr. med. Achim Mumme, Bochum

Director of the Clinic of Vascular Surgery
St. Josef-Hospital
at the Catholic Hospital Bochum
and Ruhr University Bochum

Prof. Dr. med. Stefanie Reich-Schupke, Bochum

Specialist in dermatology and venereology, endowed professorship phlebology

Prof. Dr. med. Anke Strölin, Tübingen

Senior Physician
University Department of Dermatology Tübingen

Prof. Dr. med. Markus Stücker, Bochum

Ltd. Doctor Interdisciplinary Venous Center, Managing Director of the Department of Dermatology, Venereology and Allergology St.-Josef-Hospital

Justine Whitaker MSc, RN., Lancashire

Director, Nurse Consultant and Senior Lecturer, Uclan, UK
Northern Lymphology Ltd